ICCC - ImmuCell Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

ImmuCell Corporation

56 Evergreen Drive
Portland, ME 04103
United States
207-878-2770
http://immucell.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees51

Key Executives

NameTitlePayExercisedYear Born
Mr. Michael F. BrighamPres, CEO, Principal Financial Officer, Treasurer, Sec. & Director336.88kN/A1961
Dr. Joseph H. Crabb Ph.D.VP & Chief Scientific Officer62kN/A1955
Ms. Bobbi Jo BrockmannVP of Sales & Marketing and Director258.31kN/A1977
Ms. Elizabeth L. WilliamsVP of Manufacturing Operations240kN/A1956
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ImmuCell Corporation, an animal health company, develops, acquires, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company offers First Defense, an orally delivered scours preventive product for calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic. In addition, the company is involved in developing Re-Tain, a Nisin-based treatment of subclinical mastitis in lactating dairy cows; and offers Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. ImmuCell Corporation sells its products through animal health distributors. The company was founded in 1982 and is headquartered in Portland, Maine.

Corporate Governance

ImmuCell Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.